Last reviewed · How we verify
Sildenafil Citrate in G allele carrier — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Sildenafil Citrate in G allele carrier (Sildenafil Citrate in G allele carrier) — Vanderbilt University Medical Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Sildenafil Citrate in G allele carrier TARGET | Sildenafil Citrate in G allele carrier | Vanderbilt University Medical Center | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Sildenafil Citrate in G allele carrier CI watch — RSS
- Sildenafil Citrate in G allele carrier CI watch — Atom
- Sildenafil Citrate in G allele carrier CI watch — JSON
- Sildenafil Citrate in G allele carrier alone — RSS
Cite this brief
Drug Landscape (2026). Sildenafil Citrate in G allele carrier — Competitive Intelligence Brief. https://druglandscape.com/ci/sildenafil-citrate-in-g-allele-carrier. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab